Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) announced today the launch of Accenture Accelerated R&D Services, a business service focused on delivering streamlined and integrated research and development (R&D) functions that will help pharmaceutical companies bring new medications to patients using a more collaborative and efficient approach. Accenture is investing more than $200 million to deliver this fully-integrated, technology-enabled global business service that will drive more efficient and effective development of pharmaceutical products for clients.
Help employers find you! Check out all the jobs and post your resume.
NEW YORK--(BUSINESS WIRE)--Accenture (NYSE: ACN) announced today the launch of Accenture Accelerated R&D Services, a business service focused on delivering streamlined and integrated research and development (R&D) functions that will help pharmaceutical companies bring new medications to patients using a more collaborative and efficient approach. Accenture is investing more than $200 million to deliver this fully-integrated, technology-enabled global business service that will drive more efficient and effective development of pharmaceutical products for clients.
Help employers find you! Check out all the jobs and post your resume.
